第 1 到 142 筆結果,共 142 筆。
公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 | |
---|---|---|---|---|---|---|---|
1 | 2024 | Immunogenicity and safety of heterologous booster with protein-based COVID-19 vaccine (NVX-CoV2373) in healthy adults: A comparative analysis with mRNA vaccines | WANG-HUEI SHENG ; Lin, Pin-Hung; Cheng, Yu-Chen; Wu, Yu-Yun; MING-JU HSIEH ; HUNG-CHIH YANG ; SUI-YUAN CHANG ; SHAN-CHWEN CHANG | Journal of the Formosan Medical Association = Taiwan yi zhi | 1 | ||
2 | 2024 | Tenofovir versus entecavir on recurrence and mortality of hepatitis B virus-related hepatocellular carcinoma after curative therapy | Chang, Kai-Chun; TUNG-HUNG SU ; SIH-HAN LIAO ; TAI-CHUNG TSENG ; SHANG-CHIN HUANG ; SHIH-JER HSU ; CHUN-MING HONG ; CHEN-HUA LIU ; HUNG-CHIH YANG ; CHUN-JEN LIU ; JIA-HORNG KAO | Journal of the Formosan Medical Association = Taiwan yi zhi | |||
3 | 2024 | HBcrAg-based risk score performs better than the HBV DNA-based scores for HCC prediction in grey zone patients who are HBeAg-negative | TAI-CHUNG TSENG ; Hosaka, Tetsuya; CHUN-JEN LIU ; Suzuki, Fumitaka; Chiang, Chieh; CHUN-MING HONG ; Kumada, Hiromitsu; Yang, Wan-Ting; TUNG-HUNG SU ; HUNG-CHIH YANG ; CHEN-HUA LIU ; PEI-JER CHEN ; JIA-HORNG KAO | JHEP reports : innovation in hepatology | |||
4 | 2024 | Metabolic Dysfunction-Associated Steatotic Liver Disease Facilitates Hepatitis B Surface Antigen Seroclearance and Seroconversion | SHANG-CHIN HUANG ; TUNG-HUNG SU ; TAI-CHUNG TSENG ; CHI-LING CHEN ; SHIH-JER HSU ; CHEN-HUA LIU ; SIH-HAN LIAO ; CHUN-MING HONG ; Lan, Ting Yuan; HUNG-CHIH YANG ; CHUN-JEN LIU ; PEI-JER CHEN ; JIA-HORNG KAO | Clinical Gastroenterology and Hepatology | 2 | ||
5 | 2024 | Antagonism Between Gut Ruminococcus gnavus and Akkermansia muciniphila Modulates the Progression of Chronic Hepatitis B | Chua, Huey-Huey; Chen, Ya-Hui; Wu, Li-Ling; HUNG-CHIH YANG ; Lin, Chia-Ray; HUEY-LING CHEN ; JIA-FENG WU ; MEI-HWEI CHANG ; PEI-JER CHEN ; YEN-HSUAN NI | Cellular and molecular gastroenterology and hepatology | |||
6 | 2024 | Hepatitis B reactivation: A possible cause of coronavirus disease 2019 vaccine induced hepatitis | Wu, Hsin-Yun; TUNG-HUNG SU ; CHUN-JEN LIU ; HUNG-CHIH YANG ; JIA-HUEI TSAI ; Wei, Ming-Han; CHIEH-CHANG CHEN ; CHIEN-CHIH TUNG ; JIA-HORNG KAO ; PEI-JER CHEN | Journal of the Formosan Medical Association = Taiwan yi zhi | 2 | 0 | |
7 | 2023 | Optimizing Survival Benefit by Surgical Resection by the Seven-Eleven Criteria in Barcelona Clinic Liver Cancer Stage A/B Hepatocellular Carcinoma beyond the Milan Criteria | Huang, Chian Tzu; Chu, Yu Long; TUNG-HUNG SU ; SHANG-CHIN HUANG ; TAI-CHUNG TSENG ; SHIH-JER HSU ; SIH-HAN LIAO ; CHUN-MING HONG ; CHEN-HUA LIU ; HUNG-CHIH YANG ; CHUN-JEN LIU ; PEI-JER CHEN ; JIA-HORNG KAO | Liver Cancer | |||
8 | 2023 | Current practice and recommendations for management of hepatitis B virus in people living with HIV in Asia | Lui, Grace Chung-Yan; Wong, Grace Lai-Hung; HUNG-CHIH YANG ; WANG-HUEI SHENG ; Lee, Sun Hee | HIV medicine | 0 | 0 | |
9 | 2023 | Association of vaccine-specific regulatory T cells with reduced antibody response to repeated influenza vaccination | Lin, Pin-Hung; Hsiao, Po-Ju; Pan, Ching-Fu; Liu, Ming-Tsan; JANN-TAY WANG ; Ching, Chi; Wu, Fang-Yi; Lin, Yi-Hsuan; Yang, Yu-Chan; Hsu, Le-Yin; HUNG-CHIH YANG ; UN-IN WU | European journal of immunology | 0 | 0 | |
10 | 2023 | Serum cytokine profiles predict outcomes of chronic hepatitis B patients discontinuing entecavir or tenofovir therapy | Lin, Meng-Ju; TUNG-HUNG SU ; CHUN-JEN LIU ; HUNG-CHIH YANG ; CHI-LING CHEN ; JYH-MING LIOU ; TAI-CHUNG TSENG ; CHEN-HUA LIU ; CHUN-MING HONG ; PEI-JER CHEN ; JIA-HORNG KAO | Journal of the Formosan Medical Association = Taiwan yi zhi | 2 | 1 | |
11 | 2023 | Correction: Diversity and composition of gut microbiota in healthy individuals and patients at different stages of hepatitis B virus-related liver disease | Lin, Meng-Ju; TUNG-HUNG SU ; CHIEH-CHANG CHEN ; WEI-KAI WU ; SHIH-JER HSU ; TAI-CHUNG TSENG ; SIH-HAN LIAO ; CHUN-MING HONG ; HUNG-CHIH YANG ; CHUN-JEN LIU ; MING-SHIANG WU ; JIA-HORNG KAO | Gut pathogens | 0 | 0 | |
12 | 2023 | Serial increase and high alpha-fetoprotein levels predict the development of hepatocellular carcinoma in 6 months | TUNG-HUNG SU ; Chang, Shan-Han; CHI-LING CHEN ; SIH-HAN LIAO ; TAI-CHUNG TSENG ; SHIH-JER HSU ; CHUN-MING HONG ; CHEN-HUA LIU ; HUNG-CHIH YANG ; CHUN-JEN LIU ; PEI-JER CHEN ; JIA-HORNG KAO | Hepatology research : the official journal of the Japan Society of Hepatology | 1 | 0 | |
13 | 2023 | Distinct effects of hepatic steatosis and metabolic dysfunction on the risk of hepatocellular carcinoma in chronic hepatitis B | SHANG-CHIN HUANG ; TUNG-HUNG SU ; TAI-CHUNG TSENG ; CHI-LING CHEN ; SHIH-JER HSU ; SIH-HAN LIAO ; CHUN-MING HONG ; CHEN-HUA LIU ; Lan, Ting-Yuan; HUNG-CHIH YANG ; CHUN-JEN LIU ; PEI-JER CHEN ; JIA-HORNG KAO | Hepatology international | 5 | 2 | |
14 | 2023 | Diversity and composition of gut microbiota in healthy individuals and patients at different stages of hepatitis B virus-related liver disease | Lin, Meng-Ju; TUNG-HUNG SU ; CHIEH-CHANG CHEN ; WEI-KAI WU ; SHIH-JER HSU ; TAI-CHUNG TSENG ; SIH-HAN LIAO ; CHUN-MING HONG ; HUNG-CHIH YANG ; CHUN-JEN LIU ; MING-SHIANG WU ; JIA-HORNG KAO | Gut pathogens | 2 | 2 | |
15 | 2023 | Pre-operative gamma-glutamyl transferase levels predict outcomes in hepatitis B-related hepatocellular carcinoma after curative resection | TUNG-HUNG SU ; SHANG-CHIN HUANG ; CHI-LING CHEN ; SHIH-JER HSU ; SIH-HAN LIAO ; CHUN-MING HONG ; TAI-CHUNG TSENG ; CHEN-HUA LIU ; HUNG-CHIH YANG ; YAO-MING WU ; CHUN-JEN LIU ; PEI-JER CHEN ; JIA-HORNG KAO | Journal of the Formosan Medical Association = Taiwan yi zhi | 2 | 0 | |
16 | 2023 | Low Hepatitis B Core-Related Antigen Levels Correlate Higher Spontaneous Seroclearance of Hepatitis B Surface Antigen in Chronic Hepatitis B Patients With High Hepatitis B Surface Antigen Levels | TAI-CHUNG TSENG ; Chiang, Chieh; CHUN-JEN LIU ; CHUN-MING HONG ; TUNG-HUNG SU ; HUNG-CHIH YANG ; Yang, Wan-Ting; CHEN-HUA LIU ; PEI-JER CHEN ; JIA-HORNG KAO | Gastroenterology | 4 | 4 | |
17 | 2023 | Immunogenicity and safety of third-dose mRNA COVID-19 vaccines in healthy adults previously vaccinated with two doses of the ChAdOx1 vaccine | WANG-HUEI SHENG ; Ieong, Si-Man; Lin, Pin-Hung; MING-JU HSIEH ; HUNG-CHIH YANG ; Pan, Ching-Fu; TAI-LING CHAO ; SUI-YUAN CHANG ; SHAN-CHWEN CHANG | Journal of the Formosan Medical Association = Taiwan yi zhi | 7 | 4 | |
18 | 2023 | Risk of Hepatitis B Virus (HBV) Reactivation in HBsAg-Negative, Anti-HBc-Negative Patients Receiving Rituximab for Autoimmune Diseases in HBV Endemic Areas | Lan, Ting-Yuan; Lin, Yen-Chun; TAI-CHUNG TSENG ; HUNG-CHIH YANG ; JUI-HUNG KAO ; CHIAO-FENG CHENG ; Lee, Tai-Ju; SHANG-CHIN HUANG ; CHENG-HSUN LU ; Li, Ko-Jen; SONG-CHOU HSIEH | Gut and liver | 1 | 2 | |
19 | 2022 | Chemokine CCL5 immune subtypes of human liver cancer with prognostic significance | Xia, Yin; Zhou, Linlin; HUNG-CHIH YANG ; Yu, Chen-Wei | International immunopharmacology | 1 | ||
20 | 2022 | Prothrombin induced by vitamin K absence or antagonist-II (PIVKA-II) predicts complete responses of transarterial chemoembolization for hepatocellular carcinoma | Wang, Sung-Yin; TUNG-HUNG SU ; BANG-BIN CHEN ; CHUN-JEN LIU ; CHEN-HUA LIU ; HUNG-CHIH YANG ; TAI-CHUNG TSENG ; PEI-JER CHEN ; JIA-HORNG KAO | Journal of the Formosan Medical Association = Taiwan yi zhi | 4 | 4 | |
21 | 2022 | Hepatitis B Core-Related Antigen Stratifies the Risk of Liver Cancer in HBeAg-Negative Patients With Indeterminate Phase | TAI-CHUNG TSENG ; Hosaka, Tetsuya; CHUN-JEN LIU ; Suzuki, Fumitaka; CHUN-MING HONG ; Kumada, Hiromitsu; Yang, Wan-Ting; Hsu, Chen-Yang; TUNG-HUNG SU ; HUNG-CHIH YANG ; CHEN-HUA LIU ; PEI-JER CHEN ; HSIU-HSI CHEN ; JIA-HORNG KAO | The American journal of gastroenterology | 14 | 12 | |
22 | 2022 | Serum cytokine/chemokine profiles predict hepatitis B reactivation in HBV/HCV co-infected subjects receiving direct-acting antiviral agents | SHANG-CHIN HUANG ; Cheng, Pin-Nan; CHEN-HUA LIU ; HUNG-CHIH YANG ; TUNG-HUNG SU ; TAI-CHUNG TSENG ; PEI-JER CHEN ; JIA-HORNG KAO ; CHUN-JEN LIU | Journal of the Formosan Medical Association = Taiwan yi zhi | 8 | 11 | |
23 | 2022 | Immune response and safety of heterologous ChAdOx1-nCoV-19/mRNA-1273 vaccination compared with homologous ChAdOx1-nCoV-19 or homologous mRNA-1273 vaccination | WANG-HUEI SHENG ; SUI-YUAN CHANG ; Lin, Pin-Hung; MING-JU HSIEH ; HAO-HSIANG CHANG ; Cheng, Chien-Yu; HUNG-CHIH YANG ; Pan, Ching-Fu; Ieong, Si-Man; TAI-LING CHAO ; Chen, Jang-Pin; Cheng, Shu-Hsing; SHAN-CHWEN CHANG | Journal of the Formosan Medical Association = Taiwan yi zhi | 22 | 18 | |
24 | 2022 | Hepatocellular carcinoma after treatment cessation in non-cirrhotic HBeAg-negative chronic hepatitis B: A multicentre cohort study | Papatheodoridi, Margarita; TUNG-HUNG SU ; Hadziyannis, Emilia; Liao, Chun-Hsun; Orfanidou, Αfroditi; HUNG-CHIH YANG ; Zachou, Kalliopi; CHUN-JEN LIU ; Kourikou, Anastasia; Gatselis, Nikolaos; Manolakopoulos, Spilios; Dalekos, George; JIA-HORNG KAO ; Hadziyannis, Stephanos; Papatheodoridis, George V | Liver international : official journal of the International Association for the Study of the Liver | 8 | 7 | |
25 | 2022 | Serum PIVKA-II and alpha-fetoprotein at virological remission predicts hepatocellular carcinoma in chronic hepatitis B related cirrhosis | TUNG-HUNG SU ; Peng, Cheng-Yuan; Chang, Shan-Han; TAI-CHUNG TSENG ; CHUN-JEN LIU ; CHI-LING CHEN ; CHEN-HUA LIU ; HUNG-CHIH YANG ; PEI-JER CHEN ; JIA-HORNG KAO | Journal of the Formosan Medical Association = Taiwan yi zhi | 11 | 10 | |
26 | 2022 | Dynamics of cellular immune responses in recipients of renal allografts positive for hepatitis B surface antigen | YA-WEN YANG ; CHIEN-CHIA CHEN ; CHING-YAO YANG ; CHIH-YUAN LEE ; HUNG-CHIH YANG ; BOR-LUEN CHIANG ; YA-HUI CHUANG ; Wu, Tiffany E; HONG-SHIEE LAI ; MENG-KUN TSAI | Journal of the Formosan Medical Association = Taiwan yi zhi | 1 | 1 | |
27 | 2022 | Recent Progress and Future Prospective in HBV Cure by CRISPR/Cas | Yang, Yu-Chan; HUNG-CHIH YANG | Viruses | 14 | 11 | |
28 | 2022 | Transporter Genes and fosA Associated With Fosfomycin Resistance in Carbapenem-Resistant Klebsiella pneumoniae | Wang, Yu-Ping; Chen, Yen-Hao; Hung, I-Cheng; Chu, Po-Hsun; Chang, Yu-Han; Lin, Yi-Tsung; HUNG-CHIH YANG ; JIN-TOWN WANG | Frontiers in microbiology | 9 | 8 | |
29 | 2021 | Correction to: Combined viral quasispecies diversity and hepatitis B core-related antigen predict off-nucleos(t)ide analog durability in HBeAg-negative patients | Cheng, Huei-Ru; HUNG-CHIH YANG ; Lin, Su-Ru; Yang, Ta-Yu; Lin, You-Yu; TUNG-HUNG SU ; TAI-CHUNG TSENG ; CHUN-JEN LIU ; JIA-HORNG KAO | Hepatology international | 0 | 0 | |
30 | 2021 | Risk scores to predict HCC and the benefits of antiviral therapy for CHB patients in gray zone of treatment guidelines | Teng, Wei; Chang, Ting-Tsung; Yang, Hwai-I; Peng, Cheng-Yuan; Su, Chien-Wei; TUNG-HUNG SU ; Hu, Tsung-Hui; Yu, Ming-Lung; HUNG-CHIH YANG ; Wu, Jaw-Ching | Hepatology international | 15 | 11 | |
31 | 2021 | Isolation or De-isolation? Measuring the Infectivity of Severe Acute Respiratory Syndrome Coronavirus 2 | HUNG-CHIH YANG | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 0 | 0 | |
32 | 2021 | Drug Resistance Profile and Clinical Features for Hepatitis C Patients Experiencing DAA Failure in Taiwan | CHUN-MING HONG ; Lin, You-Yu; CHUN-JEN LIU ; Lai, Ya-Yun; Shiou-Hwei Yeh ; HUNG-CHIH YANG ; JIA-HORNG KAO ; SHIH-JER HSU ; Huang, Yi-Hsiang; Yang, Sheng-Shun; Kuo, Hsing-Tao; Cheng, Pin-Nan; Yu, Ming-Lung; PEI-JER CHEN | Viruses | 5 | 2 | |
33 | 2021 | Viral and host factors affecting disease progression of hepatitis B virus infection | HUNG-CHIH YANG ; TUNG-HUNG SU | Hepatitis B Virus and Liver Disease | |||
34 | 2021 | Whole genome deep sequencing analysis of viral quasispecies diversity and evolution in HBeAg seroconverters | Lin, Su Ru; Yang, Ta Yu; Peng, Cheng Yuan; Lin, You Yu; Dai, Chia Yen; HURNG-YI WANG ; TUNG-HUNG SU ; TAI-CHUNG TSENG ; Liu, I. Jung; Cheng, Huei Ru; Shen, Yueh Chi; Wu, Fang Yi; CHUN-JEN LIU ; DING-SHINN CHEN; PEI-JER CHEN ; HUNG-CHIH YANG ; JIA-HORNG KAO | JHEP Reports | 8 | 6 | |
35 | 2021 | Combined viral quasispecies diversity and hepatitis B core-related antigen predict off-nucleos(t)ide analog durability in HBeAg-negative patients | Cheng, Huei-Ru; HUNG-CHIH YANG ; Lin, Su-Ru; Yang, Ta-Yu; Lin, You-Yu; TUNG-HUNG SU ; TAI-CHUNG TSENG ; CHUN-JEN LIU ; JIA-HORNG KAO | Hepatology international | 4 | 4 | |
36 | 2021 | Direct comparison of biopsy techniques for hepatic malignancies | SHANG-CHIN HUANG ; JA-DER LIANG ; SHIH-JER HSU ; TZU-CHAN HONG ; HUNG-CHIH YANG ; JIA-HORNG KAO | Clinical and molecular hepatology | 10 | 9 | |
37 | 2021 | Serum hepatitis B core-related antigen level stratifies risk of disease progression in chronic hepatitis B patients with intermediate viral load | TAI-CHUNG TSENG ; CHUN-JEN LIU ; Yang W.-T; Hsu C.-Y; CHUN-MING HONG ; TUNG-HUNG SU ; Tsai C.-H; CHI-LING CHEN ; HUNG-CHIH YANG ; CHEN-HUA LIU ; Chen, Tony Hsiu Hsi ; PEI-JER CHEN ; JIA-HORNG KAO | Alimentary Pharmacology and Therapeutics | 14 | 15 | |
38 | 2021 | Clinical and histologic features of patients with biopsy-proven metabolic dysfunction-associated fatty liver disease | SHANG-CHIN HUANG ; Su H.-J; JIA-HORNG KAO ; TAI-CHUNG TSENG ; HUNG-CHIH YANG ; TUNG-HUNG SU ; PEI-JER CHEN ; CHUN-JEN LIU | Gut and Liver | 38 | 32 | |
39 | 2020 | Seroprevalence of Aspergillus IgG and disease prevalence of chronic pulmonary aspergillosis in a country with intermediate burden of tuberculosis: a prospective observational study | MENG-RUI LEE ; Huang H.-L; LUN-CHE CHEN ; HUNG-CHIH YANG ; JEN-CHUNG KO ; Cheng M.-H; Chong I.-W; LI-NA LEE ; JANN-YUAN WANG ; Dimopoulos G. | Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 21 | 19 | |
40 | 2020 | Epidemiology and management of HCV Infection | HUNG-CHIH YANG | East Asian Archives of Psychiatry | 0 | 0 | |
41 | 2020 | Baseline Mac-2 Binding Protein Glycosylation Isomer Level Stratifies Risks of Hepatocellular Carcinoma in Chronic Hepatitis B Patients with Oral Antiviral Therapy | TAI-CHUNG TSENG ; Peng C.-Y; Hsu Y.-C; TUNG-HUNG SU ; Wang C.-C; CHUN-JEN LIU ; HUNG-CHIH YANG ; Yang W.-T; Lin C.-H; Yu M.-L; Lai H.-C; Tanaka Y; Nguyen M.H; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Liver Cancer | 17 | 13 | |
42 | 2020 | Pathologic findings of patients with nonalcoholic fatty liver disease and the impact of concurrent hepatitis B virus infection in Taiwan | Su H.-J.; JIA-HORNG KAO ; TAI-CHUNG TSENG ; HUNG-CHIH YANG ; TUNG-HUNG SU ; PEI-JER CHEN ; CHUN-JEN LIU | Journal of the Formosan Medical Association | 17 | 12 | |
43 | 2020 | Antiviral therapy against chronic hepatitis C is associated with a reduced risk of oral cancer | TUNG-HUNG SU ; TAI-CHUNG TSENG ; CHUN-JEN LIU ; Chou S.-W; CHEN-HUA LIU ; HUNG-CHIH YANG ; PEI-JER CHEN ; DING-SHINN CHEN ; CHI-LING CHEN ; JIA-HORNG KAO | International Journal of Cancer | 4 | 4 | |
44 | 2020 | Benzarone-induced liver injury: First case report in Asia | Tseng H.-H; Tseng L.-W; HUNG-CHIH YANG | Journal of the Formosan Medical Association | 1 | 1 | |
45 | 2020 | High risk of clinical relapse in patients with chronic Hepatitis B virus infection after cessation of prophylactic antiviral therapy for rituximab-containing chemotherapy | Chang W.-Y.; Chiu Y.-C; Chiu F.-W; Hsu Y.-C; TAI-CHUNG TSENG ; Cheng P.-N; Yang S.-S; CHUN-JEN LIU ; TUNG-HUNG SU ; HUNG-CHIH YANG ; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of Infectious Diseases | 5 | 5 | |
46 | 2020 | Permanent Inactivation of HBV Genomes by CRISPR/Cas9-Mediated Non-cleavage Base Editing | Yang Y.-C.; Chen Y.-H; JIA-HORNG KAO ; Ching C; Liu I.-J; Wang C.-C; Tsai C.-H; Wu F.-Y; CHUN-JEN LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; HUNG-CHIH YANG | Molecular Therapy - Nucleic Acids | 59 | 52 | |
47 | 2020 | Cost-effectiveness of preventing hepatitis B virus reactivation in patients with lymphoma and resolved HBV infection | Tsou H.-H.; HUNG-CHIH YANG ; Hsiao C.-F; Hsiung C.A; Liu T.-W; Chuang M.-H; Wu H.-Y; Hsu Y.-T; Tsui C.-W; PEI-JER CHEN ; ANN-LII CHENG ; CHIUN HSU ; Taiwan Cooperative Oncology Group | Journal of the Formosan Medical Association | 8 | 8 | |
48 | 2020 | Serum Mac-2-Binding Protein Glycosylation Isomer at Virological Remission Predicts Hepatocellular Carcinoma and Death in Chronic Hepatitis B-Related Cirrhosis | TUNG-HUNG SU ; Peng C.-Y; TAI-CHUNG TSENG ; HUNG-CHIH YANG ; CHUN-JEN LIU ; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of Infectious Diseases | 10 | 8 | |
49 | 2020 | HEV superinfection accelerates disease progression in patients with chronic HBV infection and increases mortality in those with cirrhosis | TAI-CHUNG TSENG ; CHUN-JEN LIU ; Chang C.T; TUNG-HUNG SU ; Yang W.-T; Tsai C.-H; CHI-LING CHEN ; HUNG-CHIH YANG ; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of Hepatology | 41 | 32 | |
50 | 2020 | Relationship between serum gamma-glutamyl transferase level and colorectal adenoma | TZU-CHAN HONG ; HUNG-CHIH YANG ; CHI-LING CHEN ; JIA-HORNG KAO ; CHUN-JEN LIU ; Chen M.-J; Wang H.-Y; Kuo Y.-C; Yu L.-Y; Hu K.-C. | PLoS ONE | 4 | 2 | |
51 | 2020 | Hepatitis B reactivation: diagnosis and management | SHANG-CHIN HUANG ; HUNG-CHIH YANG ; JIA-HORNG KAO | Expert Review of Gastroenterology and Hepatology | 18 | 15 | |
52 | 2020 | Towards elimination of viral hepatitis in Taiwan by 2025: In memory of Professor Ding-Shinn Chen (1943-2020) | HUNG-CHIH YANG ; JIA-HORNG KAO | Journal of the Formosan Medical Association | 3 | 2 | |
53 | 2020 | Real-world effectiveness of direct-acting antiviral agents for chronic hepatitis C in Taiwan: Real-world data | CHUN-MING HONG ; CHEN-HUA LIU ; TUNG-HUNG SU ; HUNG-CHIH YANG ; PEI-JER CHEN ; Chen Y.-W; JIA-HORNG KAO ; CHUN-JEN LIU | Journal of Microbiology, Immunology and Infection | 17 | 18 | |
54 | 2019 | Antiviral Therapy in Patients With Chronic Hepatitis C Is Associated With a Reduced Risk of Parkinsonism | TUNG-HUNG SU ; HUNG-CHIH YANG ; TAI-CHUNG TSENG ; Chou S.-W; CHIN-HSIEN LIN ; CHEN-HUA LIU ; CHUN-JEN LIU ; CHI-LING CHEN ; JIA-HORNG KAO | Movement Disorders | 14 | 14 | |
55 | 2019 | Chronic hepatitis B is associated with an increased risk of B-cell non-Hodgkin's lymphoma and multiple myeloma | TUNG-HUNG SU ; CHUN-JEN LIU ; TAI-CHUNG TSENG ; Chou S.-W; CHEN-HUA LIU ; HUNG-CHIH YANG ; SHANG-JU WU ; PEI-JER CHEN ; DING-SHINN CHEN ; CHI-LING CHEN ; JIA-HORNG KAO | Alimentary Pharmacology and Therapeutics | 29 | 26 | |
56 | 2019 | Sofosbuvir-based direct acting antiviral therapies for patients with hepatitis C virus genotype 2 infection | CHEN-HUA LIU ; TUNG-HUNG SU ; CHUN-JEN LIU ; CHUN-MING HONG ; HUNG-CHIH YANG ; TAI-CHUNG TSENG ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of Gastroenterology and Hepatology (Australia) | 14 | 15 | |
57 | 2019 | Profile and value of FIB-4 in patients with dual chronic hepatitis C and B | CHUN-JEN LIU ; TAI-CHUNG TSENG ; Yang W.-T; TUNG-HUNG SU ; HUNG-CHIH YANG ; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of Gastroenterology and Hepatology (Australia) | 10 | 9 | |
58 | 2019 | Paritaprevir/ritonavir, ombitasvir plus dasabuvir for East Asian non-cirrhotic hepatitis C virus genotype 1b patients receiving hemodialysis | CHEN-HUA LIU ; Shih Y.-L; Yang S.-S; Lin C.-L; YU-JEN FANG ; Cheng P.-N; Chen C.-Y; Peng C.-Y; Hsieh T.-Y; Chiu Y.-C; TUNG-HUNG SU ; CHUN-JEN LIU ; HUNG-CHIH YANG ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of Gastroenterology and Hepatology (Australia) | 7 | 7 | |
59 | 2019 | High Level of Hepatitis B Core–Related Antigen Associated With Increased Risk of Hepatocellular Carcinoma in Patients With Chronic HBV Infection of Intermediate Viral Load | TAI-CHUNG TSENG ; CHUN-JEN LIU ; Hsu C.-Y; CHUN-MING HONG ; TUNG-HUNG SU ; Yang W.-T; CHI-LING CHEN ; HUNG-CHIH YANG ; Huang Y.-T; Fang-Tzu Kuo S; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Gastroenterology | 94 | 76 | |
60 | 2019 | NIACE score refines the overall survival of hepatocellular carcinoma by Barcelona clinic liver cancer staging | TUNG-HUNG SU ; SIH-HAN LIAO ; CHUN-MING HONG ; CHUN-JEN LIU ; TAI-CHUNG TSENG ; CHEN-HUA LIU ; HUNG-CHIH YANG ; PEI-JER CHEN ; DING-SHINN CHEN ; CHI-LING CHEN ; Adhoute X; Bourlière M; JIA-HORNG KAO | Journal of Gastroenterology and Hepatology (Australia) | 3 | 3 | |
61 | 2019 | Quantification of HBV core antibodies may help revisit infectious occult hepatitis B virus | HUNG-CHIH YANG ; JIA-HORNG KAO | Gut | 4 | 2 | |
62 | 2019 | Early antiviral therapy reduces the risk of lymphoma in patients with chronic hepatitis C infection | TUNG-HUNG SU ; CHUN-JEN LIU ; TAI-CHUNG TSENG ; Chou S.-W; CHEN-HUA LIU ; HUNG-CHIH YANG ; SHANG-JU WU ; PEI-JER CHEN ; DING-SHINN CHEN ; CHI-LING CHEN ; JIA-HORNG KAO | Alimentary Pharmacology and Therapeutics | 10 | 9 | |
63 | 2019 | A global scientific strategy to cure hepatitis B | Revill P.A; Chisari F.V; Block J.M; Dandri M; Gehring A.J; Guo H; Hu J; Kramvis A; Lampertico P; Janssen H.L.A; Levrero M; Li W; Liang T.J; Lim S.-G; Lu F; Penicaud M.C; Tavis J.E; Thimme R; Arbuthnot P; Boonstra A; Chang K.-M; PEI-JER CHEN ; Glebe D; Guidotti L.G; Fellay J; Ferrari C; Jansen L; Lau D.T.Y; Lok A.S; Maini M.K; Mason W; Matthews G; Paraskevis D; Petersen J; Rehermann B; Shin E.-C; Thompson A; van Bömmell F; Wang F.-S; Watashi K; HUNG-CHIH YANG ; Yuan Z; Yuen M.-F; Block T; Miller V; Protzer U; Bréchot C; Locarnini S; Peters M.G; Schinazi R.F; Zoulim F; Members of the ICE-HBV Working Groups, ICE-HBV Stakeholders Group Chairs, ICE-HBV Senior Advisors | The Lancet Gastroenterology and Hepatology | 338 | 282 | |
64 | 2019 | Lymphocyte Antigen 6 Complex, Locus C+ Monocytes and Kupffer Cells Orchestrate Liver Immune Responses Against Hepatitis B Virus in Mice | Wu, Li-Ling; Peng, Wei-Hao; Wu, Hui-Lin; SHI-CHUEN MIAW ; Shiou-Hwei Yeh ; HUNG-CHIH YANG ; Liao, Pei-Hsuan; Lin, Jing-Shan; Chen, Yan-Rong; Hong, Yen-Tien; HURNG-YI WANG ; PEI-JER CHEN ; DING-SHINN CHEN | Hepatology | 31 | 27 | |
65 | 2018 | Viral factors affecting disease progression | HUNG-CHIH YANG | Hepatitis B Virus and Liver Disease | 1 | 0 | |
66 | 2018 | Fibrosis-4 index predicts cirrhosis risk and liver-related mortality in 2075 patients with chronic HBV infection | TAI-CHUNG TSENG ; CHUN-JEN LIU ; TUNG-HUNG SU ; Yang W.-T; CHI-LING CHEN ; HUNG-CHIH YANG ; Kuo S.F.-T; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Alimentary Pharmacology and Therapeutics | 18 | 18 | |
67 | 2018 | Real-world effectiveness and safety of paritaprevir/ritonavir, ombitasvir, and dasabuvir with or without ribavirin for patients with chronic hepatitis C virus genotype 1b infection in Taiwan | CHEN-HUA LIU ; CHUN-JEN LIU ; TUNG-HUNG SU ; HUNG-CHIH YANG ; CHUN-MING HONG ; TAI-CHUNG TSENG ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of Gastroenterology and Hepatology (Australia) | 25 | 24 | |
68 | 2018 | The potential and challenges of CRISPR-Cas in eradication of hepatitis B virus covalently closed circular DNA | HUNG-CHIH YANG ; PEI-JER CHEN | Virus Research | 41 | 33 | |
69 | 2018 | Sofosbuvir-based Interferon-Free Direct Acting Antiviral Regimens for Heart Transplant Recipients with Chronic Hepatitis C Virus Infection | CHEN-HUA LIU ; YIH-SHARNG CHEN ; SHOEI-SHEN WANG ; CHUN-JEN LIU ; TUNG-HUNG SU ; HUNG-CHIH YANG ; CHUN-MING HONG ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Clinical Infectious Diseases | 26 | 21 | |
70 | 2018 | Significance of definitions of relapse after discontinuation of oral antivirals in HBeAg-negative chronic hepatitis B | Papatheodoridis G.V.; Manolakopoulos S; TUNG-HUNG SU ; Siakavellas S; CHUN-JEN LIU ; Kourikou A; HUNG-CHIH YANG ; JIA-HORNG KAO | Hepatology | 45 | 39 | |
71 | 2018 | Generic velpatasvir plus sofosbuvir for hepatitis C virus infection in patients with or without human immunodeficiency virus coinfection | CHEN-HUA LIU ; HSIN-YUN SUN ; CHUN-JEN LIU ; WANG-HUEI SHENG ; SZU-MIN HSIEH ; Lo Y.-C; Liu W.-C; TUNG-HUNG SU ; HUNG-CHIH YANG ; CHUN-MING HONG ; TAI-CHUNG TSENG ; PEI-JER CHEN ; DING-SHINN CHEN ; CHIEN-CHING HUNG ; JIA-HORNG KAO | Alimentary Pharmacology and Therapeutics | 25 | 21 | |
72 | 2018 | Quantification of HBV core antibodies may help predict HBV reactivation in patients with lymphoma and resolved HBV infection | HUNG-CHIH YANG ; Tsou H.-H; Pei S.-N; Chang C.-S; Chen J.-H; MING YAO ; Lin S.-J; Lin J; Yuan Q; Xia N; Liu T.-W; PEI-JER CHEN ; ANN-LII CHENG ; CHIUN HSU ; Taiwan Cooperative Oncology Group | Journal of Hepatology | 69 | 58 | |
73 | 2018 | Generic sofosbuvir-based interferon-free direct acting antiviral agents for patients with chronic hepatitis C virus infection: a real-world multicenter observational study | CHEN-HUA LIU ; Huang Y.-J; Yang S.-S; Chang C.-H; Yang S.-S; HSIN-YUN SUN ; CHUN-JEN LIU ; Liu W.-C; TUNG-HUNG SU ; HUNG-CHIH YANG ; CHUN-MING HONG ; TAI-CHUNG TSENG ; PEI-JER CHEN ; DING-SHINN CHEN ; CHIEN-CHING HUNG ; JIA-HORNG KAO | Scientific Reports | 25 | 23 | |
74 | 2018 | A noninvasive diagnosis of hepatic fibrosis by BioFibroScore® in chronic hepatitis C patients | CHEN-HUA LIU ; CHUN-JEN LIU ; CHUN-MING HONG ; TUNG-HUNG SU ; HUNG-CHIH YANG ; Chen K.-M; Huang Y.-P; Yeh Y.-M; Tien H.-L; Liu Y.-C; JIA-HORNG KAO ; DING-SHINN CHEN ; PEI-JER CHEN | Journal of Gastroenterology and Hepatology (Australia) | 15 | 15 | |
75 | 2018 | Vaccine-induced antigen-specific regulatory T cells attenuate the antiviral immunity against acute influenza virus infection | Lin, Pin-Hung; Wong, Weng-In; Wang, Yi-Lan; Hsieh, Meng-Ping; CHIA-WEN LU ; Liang, Chieh-Yu; Jui, Sung-Hsiang; Wu, Fang-Yi; PEI-JER CHEN ; HUNG-CHIH YANG | Mucosal Immunology | 36 | 34 | |
76 | 2018 | Real-world effectiveness and safety of sofosbuvir and ledipasvir with or without ribavirin for patients with hepatitis C virus genotype 1 infection in Taiwan | CHEN-HUA LIU ; CHUN-JEN LIU ; TUNG-HUNG SU ; HUNG-CHIH YANG ; CHUN-MING HONG ; TAI-CHUNG TSENG ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | PLoS ONE | 11 | 10 | |
77 | 2018 | Acoustic radiation force impulse US imaging: Liver stiffness in patients with chronic hepatitis B with and without antiviral therapy | TUNG-HUNG SU ; Liao C.-H; CHEN-HUA LIU ; KAI-WEN HUANG ; TAI-CHUNG TSENG ; HUNG-CHIH YANG ; CHUN-JEN LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Radiology | 17 | 14 | |
78 | 2018 | Distinct Relapse Rates and Risk Predictors after Discontinuing Tenofovir and Entecavir Therapy | TUNG-HUNG SU ; HUNG-CHIH YANG ; TAI-CHUNG TSENG ; JYH-MING LIOU ; CHEN-HUA LIU ; CHI-LING CHEN ; PEI-JER CHEN ; DING-SHINN CHEN ; CHUN-JEN LIU ; JIA-HORNG KAO | Journal of Infectious Diseases | 57 | 52 | |
79 | 2017 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 positively modulates matrix metalloproteinase-9 production in alveolar macrophages upon toll-like receptor 7 signaling and influenza virus infection | Lee Y.-H; Huang J.-H; Chang T.-H; HUNG-CHIH YANG ; Wu-Hsieh B.A. | Frontiers in Immunology | 6 | 8 | |
80 | 2017 | More viral mutants, less HBsAg clearance? One size may not fit all | TAI-CHUNG TSENG ; HUNG-CHIH YANG ; JIA-HORNG KAO | Gut | 2 | 1 | |
81 | 2017 | Viral Factors Affecting the Clinical Outcomes of Chronic Hepatitis B | HUNG-CHIH YANG ; Shih Y.-F; CHUN-JEN LIU | Journal of Infectious Diseases | 7 | 7 | |
82 | 2017 | Hepatitis B virus reactivation in patients receiving interferon-free direct-acting antiviral agents for chronic hepatitis C virus infection | CHEN-HUA LIU ; CHUN-JEN LIU ; TUNG-HUNG SU ; YU-JEN FANG ; HUNG-CHIH YANG ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Open Forum Infectious Diseases | 42 | 39 | |
83 | 2017 | Fibrosis-4 Index Helps Identify HBV Carriers with the Lowest Risk of Hepatocellular Carcinoma | TAI-CHUNG TSENG ; CHUN-JEN LIU ; TUNG-HUNG SU ; Yang W.-T; CHI-LING CHEN ; HUNG-CHIH YANG ; Wang C.-C; Kuo S.F.-T; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | American Journal of Gastroenterology | 42 | 39 | |
84 | 2017 | Transcriptional Reprogramming during Effector-to-Memory Transition Renders CD4+ T Cells Permissive for Latent HIV-1 Infection | Shan L; Deng K; Gao H; Xing S; Capoferri A.A; Durand C.M; Rabi S.A; Laird G.M; Kim M; Hosmane N.N; HUNG-CHIH YANG ; Zhang H; Margolick J.B; Li L; Cai W; Ke R; Flavell R.A; Siliciano J.D; Siliciano R.F. | Immunity | 128 | 118 | |
85 | 2017 | Clinical Efficacy and Post-Treatment Seromarkers Associated with the Risk of Hepatocellular Carcinoma among Chronic Hepatitis C Patients | Lee M.-H.; Huang C.-F; Lai H.-C; Lin C.-Y; Dai C.-Y; CHUN-JEN LIU ; Wang J.-H; Huang J.-F; Su W.-P; HUNG-CHIH YANG ; Kee K.-M; Yeh M.-L; Chuang P.-H; SHIH-JER HSU ; Huang C.-I; JIA-HORNG KAO ; CHIEH-CHANG CHEN ; Chen S.-H; Jeng W.-J; Yang H.-I; Yuan Y; Lu S.-N; Sheen I.-S; CHEN-HUA LIU ; Peng C.-Y; Yu M.-L; Chuang W.-L; Chen C.-J. | Scientific Reports | 16 | 14 | |
86 | 2017 | Src-homology protein tyrosine phosphatase-1 agonist, SC-43, reduces liver fibrosis | TUNG-HUNG SU ; Shiau C.-W; Jao P; Yang N.-J; Tai W.-T; CHUN-JEN LIU ; TAI-CHUNG TSENG ; HUNG-CHIH YANG ; CHEN-HUA LIU ; KAI-WEN HUANG ; Hu T.-C; Huang Y.-J; YAO-MING WU ; Chen L.-J; PEI-JER CHEN ; DING-SHINN CHEN ; Chen K.-F; JIA-HORNG KAO | Scientific Reports | 12 | 11 | |
87 | 2016 | Hepatitis B surface antigen loss and hepatocellular carcinoma development in patients with dual hepatitis B and C infection | Yang W.-T.; Wu L.-W; TAI-CHUNG TSENG ; CHI-LING CHEN ; HUNG-CHIH YANG ; TUNG-HUNG SU ; Wang C.-C; Kuo S.F.-T; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; CHUN-JEN LIU ; JIA-HORNG KAO | Medicine (United States) | 20 | 15 | |
88 | 2016 | Hepatitis B virus: New therapeutic perspectives | Lin C.-L.; HUNG-CHIH YANG ; JIA-HORNG KAO | Liver International | 45 | 36 | |
89 | 2016 | Looking into the crystal ball: biomarkers for outcomes of HBV infection | HUNG-CHIH YANG ; JIA-HORNG KAO | Hepatology International | 10 | 10 | |
90 | 2016 | Hepatitis C viral infection increases the risk of lymphoid-neoplasms: A population-based cohort study | TUNG-HUNG SU ; CHUN-JEN LIU ; TAI-CHUNG TSENG ; Chou S.-W; CHEN-HUA LIU ; HUNG-CHIH YANG ; SHANG-JU WU ; PEI-JER CHEN ; DING-SHINN CHEN ; CHI-LING CHEN ; JIA-HORNG KAO | Hepatology | 35 | 31 | |
91 | 2016 | Pegylated IFN-α suppresses hepatitis C virus by promoting the DAPK-mTOR pathway | Liu W.-L.; HUNG-CHIH YANG ; Hsu C.-S; Wang C.-C; Wang T.-S; JIA-HORNG KAO ; DING-SHINN CHEN | Proceedings of the National Academy of Sciences of the United States of America | 9 | 9 | |
92 | 2015 | Peginterferon alfa-2a plus Weight-Based or Flat-Dose Ribavirin for Treatment-Naïve Hepatitis C Virus Genotype 2 Rapid Responders: A Randomized Trial | CHEN-HUA LIU ; Huang, Chung-Feng; CHUN-JEN LIU ; Dai, Chia-Yen; Huang, Jee-Fu; JOU-WEI LIN ; Liang, Cheng-Chao; Yang, Sheng-Shun; CHIH-HUNG LIN ; TUNG-HUNG SU ; HUNG-CHIH YANG ; PEI-JER CHEN ; DING-SHINN CHEN ; Chuang, Wan-Long; JIA-HORNG KAO ; Yu, Ming-Lung | Scientific reports | 8 | 8 | |
93 | 2015 | Peginterferon plus weight-based ribavirin for treatment-naïve hepatitis C virus genotype 2 patients not achieving rapid virologic response: a randomized trial | CHEN-HUA LIU ; Huang, Chung-Feng; CHUN-JEN LIU ; Dai, Chia-Yen; Huang, Jee-Fu; JOU-WEI LIN ; Liang, Cheng-Chao; Yang, Sheng-Shun; Lin, Chih-Lin; TUNG-HUNG SU ; HUNG-CHIH YANG ; PEI-JER CHEN ; DING-SHINN CHEN ; Chuang, Wan-Long; JIA-HORNG KAO ; Yu, Ming-Lung | Scientific reports | 7 | 7 | |
94 | 2015 | Liver injury in patients with DRESS: A clinical study of 72 cases | Lin, I-Chun; HUNG-CHIH YANG ; Strong, Carol; Yang, Che-Wen; YUNG-TSU CHO ; Chen, Kai-Lung; CHIA-YU CHU | Journal of the American Academy of Dermatology | 57 | 45 | |
95 | 2015 | Higher proportion of viral basal core promoter mutant increases the risk of liver cirrhosis in hepatitis B carriers | TAI-CHUNG TSENG ; CHUN-JEN LIU ; HUNG-CHIH YANG ; CHI-LING CHEN ; Yang W.-T; Tsai C.-S; Kuo S.F.-T; Verbree F.C; TUNG-HUNG SU ; Wang C.-C; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Gut | 98 | 84 | |
96 | 2015 | Viral hepatitis: HBV cure-can we pin our hopes on immunotherapy? | HUNG-CHIH YANG ; JIA-HORNG KAO | Nature Reviews Gastroenterology and Hepatology | 28 | 22 | |
97 | 2015 | Clinical significance of circulating miR-122 in patients with dual chronic hepatitis B and C virus infection | Cheng H.-R.; JIA-HORNG KAO ; Wu H.-L; TAI-CHUNG TSENG ; CHEN-HUA LIU ; HUNG-CHIH YANG ; TUNG-HUNG SU ; PEI-JER CHEN ; DING-SHINN CHEN ; CHUN-JEN LIU | Hepatology International | 14 | 11 | |
98 | 2015 | Sorafenib and its derivative SC-1 exhibit antifibrotic effects through signal transducer and activator of transcription 3 inhibition | TUNG-HUNG SU ; Shiau C.-W; Jao P; CHEN-HUA LIU ; CHUN-JEN LIU ; Tai W.-T; YUNG-MING JENG ; HUNG-CHIH YANG ; TAI-CHUNG TSENG ; HSIANG-PO HUANG ; Cheng H.-R; PEI-JER CHEN ; Chen K.-F; JIA-HORNG KAO ; DING-SHINN CHEN | Proceedings of the National Academy of Sciences of the United States of America | 65 | 62 | |
99 | 2015 | Comparison of abbott realtime HCV genotype II with versant line probe assay 2.0 for hepatitis C virus genotyping | CHEN-HUA LIU ; Liang C.-C; CHUN-JEN LIU ; Lin C.-L; TUNG-HUNG SU ; HUNG-CHIH YANG ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of Clinical Microbiology | 58 | 55 | |
100 | 2015 | Higher lifetime chance of spontaneous surface antigen loss in hepatitis B carriers with genotype C infection | TAI-CHUNG TSENG ; CHUN-JEN LIU ; CHI-LING CHEN ; Yang W.-T; HUNG-CHIH YANG ; TUNG-HUNG SU ; Wang C.-C; Kuo S.F.-T; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Alimentary Pharmacology and Therapeutics | 48 | 43 | |
101 | 2015 | Peginterferon plus Ribavirin for HIV-infected Patients with Treatment-Naive Acute or Chronic HCV Infection in Taiwan: A Prospective Cohort Study | CHEN-HUA LIU ; WANG-HUEI SHENG ; HSIN-YUN SUN ; SZU-MIN HSIEH ; Lo Y.-C; CHUN-JEN LIU ; TUNG-HUNG SU ; HUNG-CHIH YANG ; Liu W.-C; PEI-JER CHEN ; DING-SHINN CHEN ; CHIEN-CHING HUNG ; JIA-HORNG KAO | Scientific Reports | 13 | 12 | |
102 | 2015 | Peginterferon alfa-2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 2 receiving haemodialysis: A randomised trial | CHEN-HUA LIU ; CHUN-JEN LIU ; Huang C.-F; JOU-WEI LIN ; Dai C.-Y; Liang C.-C; Huang J.-F; Hung P.-H; Tsai H.-B; MENG-KUN TSAI ; CHIH-YUAN LEE ; Chen S.-I; Yang S.-S; TUNG-HUNG SU ; HUNG-CHIH YANG ; PEI-JER CHEN ; DING-SHINN CHEN ; Chuang W.-L; Yu M.-L; JIA-HORNG KAO | Gut | 36 | 30 | |
103 | 2015 | Quantitative hepatitis B core antibody levels in the natural history of hepatitis B virus infection | Song L.-W.; Liu P.-G; CHUN-JEN LIU ; Zhang T.-Y; Cheng X.-D; Wu H.-L; HUNG-CHIH YANG ; Hao X.-K; Yuan Q; Zhang J; JIA-HORNG KAO ; DING-SHINN CHEN ; PEI-JER CHEN ; Xia N.-S. | Clinical Microbiology and Infection | 98 | 86 | |
104 | 2015 | Advanced hepatic fibrosis and steatosis are associated with persistent alanine aminotransferase elevation in chronic hepatitis C patients negative for hepatitis C virus RNA during pegylated interferon plus ribavirin therapy | Liang C.-C.; CHEN-HUA LIU ; Chung C.-S; Lin C.-K; TUNG-HUNG SU ; HUNG-CHIH YANG ; CHUN-JEN LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of Infectious Diseases | 7 | 6 | |
105 | 2014 | Hepatitis B virus: Pathogenesis and host immune response | HUNG-CHIH YANG ; Shiou-Hwei Yeh ; PEI-JER CHEN ; DING-SHINN CHEN | Viruses and Human Cancer | 0 | 0 | |
106 | 2014 | The CRISPR/Cas9 system facilitates clearance of the intrahepatic HBV templates in vivo | Lin S.-R.; HUNG-CHIH YANG ; Kuo Y.-T; CHUN-JEN LIU ; Yang T.-Y; Sung K.-C; Lin Y.-Y; HURNG-YI WANG ; Wang C.-C; Shen Y.-C; Wu F.-Y; JIA-HORNG KAO ; DING-SHINN CHEN ; PEI-JER CHEN | Molecular Therapy - Nucleic Acids | 325 | 301 | |
107 | 2014 | Persistence of hepatitis B virus covalently closed circular DNA in hepatocytes: Molecular mechanisms and clinical significance | HUNG-CHIH YANG ; JIA-HORNG KAO | Emerging Microbes and Infections | 102 | 104 | |
108 | 2014 | Clinical significance and evolution of hepatic HBsAg expression in HBeAg-positive patients receiving interferon therapy | TUNG-HUNG SU ; CHUN-JEN LIU ; HUNG-CHIH YANG ; YUNG-MING JENG ; Cheng H.-R; CHEN-HUA LIU ; TAI-CHUNG TSENG ; THAI-YEN LING ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of Gastroenterology | 16 | 14 | |
109 | 2014 | Serum cytokine/chemokine profiles in acute exacerbation of chronic hepatitis B: Clinical and mechanistic implications | Wu H.-L.; JIA-HORNG KAO ; Chen T.-C; Wu W.-H; CHEN-HUA LIU ; TUNG-HUNG SU ; HUNG-CHIH YANG ; DING-SHINN CHEN ; PEI-JER CHEN ; CHUN-JEN LIU | Journal of Gastroenterology and Hepatology (Australia) | 28 | 24 | |
110 | 2014 | Hepatitis B surface antigen level complements viral load in predicting viral reactivation in spontaneous HBeAg seroconverters | TAI-CHUNG TSENG ; CHUN-JEN LIU ; Yang W.-T; CHI-LING CHEN ; HUNG-CHIH YANG ; TUNG-HUNG SU ; Wang C.-C; Kuo S.F.-T; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of Gastroenterology and Hepatology (Australia) | 13 | 9 | |
111 | 2014 | A primary CD4+ T cell model of HIV-1 latency established after activation through the T cell receptor and subsequent return to quiescence | Kim M; Hosmane N.N; Bullen C.K; Capoferri A; HUNG-CHIH YANG ; Siliciano J.D; Siliciano R.F. | Nature Protocols | 42 | 41 | |
112 | 2014 | Unique characteristics of histone deacetylase inhibitors in reactivation of latent HIV-1 in Bcl-2-transduced primary resting CD4+ Tcells | Shan L; Xing S; HUNG-CHIH YANG ; Zhang H; Margolick J.B; Siliciano R.F. | Journal of Antimicrobial Chemotherapy | 22 | 22 | |
113 | 2013 | Pegylated interferon-α2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 1 receiving hemodialysis: a randomized trial | CHEN-HUA LIU ; Huang, Chung-Feng; CHUN-JEN LIU ; Dai, Chia-Yen; Liang, Cheng-Chao; Huang, Jee-Fu; Hung, Peir-Haur; HUNG-BIN TSAI ; MENG-KUN TSAI ; Chen, Shih-I; JOU-WEI LIN ; Yang, Sheng-Shun; TUNG-HUNG SU ; HUNG-CHIH YANG ; PEI-JER CHEN ; DING-SHINN CHEN ; Chuang, Wan-Long; Yu, Ming-Lung; JIA-HORNG KAO | Annals of internal medicine | 85 | 77 | |
114 | 2013 | Sustained hepatitis C virus clearance and increased hepatitis B surface antigen seroclearance in patients with dual chronic hepatitis C and B during posttreatment follow-up | Yu M.-L.; Lee C.-M; CHI-LING CHEN ; Chuang W.-L; Lu S.-N; CHEN-HUA LIU ; Wu S.-S; Liao L.-Y; Kuo H.-T; Chao Y.-C; Tung S.-Y; Yang S.-S; JIA-HORNG KAO ; Su W.-W; Lin C.-L; HUNG-CHIH YANG ; PEI-JER CHEN ; DING-SHINN CHEN ; CHUN-JEN LIU | Hepatology | 65 | 59 | |
115 | 2013 | Risk stratification of hepatocellular carcinoma in hepatitis B virus e antigen-negative carriers by combining viral biomarkers | TAI-CHUNG TSENG ; CHUN-JEN LIU ; CHI-LING CHEN ; HUNG-CHIH YANG ; TUNG-HUNG SU ; Wang C.-C; Yang W.-T; Kuo S.F.-T; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of Infectious Diseases | 45 | 44 | |
116 | 2013 | Catechins and sialic acid attenuate helicobacter pylori -triggered epithelial caspase-1 activity and eradicate helicobacter pylori infection | JYH-CHIN YANG ; HUNG-CHIH YANG ; CHIA-TUNG SHUN ; Wang T.-H; Chien C.-T; Kao J.Y. | Evidence-based Complementary and Alternative Medicine | 28 | 20 | |
117 | 2013 | Longitudinal Change of HBsAg in HBeAg-negative Patients with Genotype B or C Infection | TUNG-HUNG SU ; CHUN-JEN LIU ; TAI-CHUNG TSENG ; CHEN-HUA LIU ; HUNG-CHIH YANG ; CHI-LING CHEN ; PEI-JER CHEN ; JIA-HORNG KAO ; DING-SHINN CHEN | PLoS ONE | 21 | 16 | |
118 | 2013 | Distinct evolution and predictive value of hepatitis B virus precore and basal core promoter mutations in interferon-induced hepatitis B e antigen seroconversion | HUNG-CHIH YANG ; CHI-LING CHEN ; Shen Y.-C; Peng C.-Y; CHUN-JEN LIU ; TAI-CHUNG TSENG ; TUNG-HUNG SU ; Chuang W.-L; Yu M.-L; Dai C.-Y; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Hepatology | 43 | 37 | |
119 | 2013 | Serum hepatitis B surface antigen levels help predict disease progression in patients with low hepatitis B virus loads | TAI-CHUNG TSENG ; CHUN-JEN LIU ; HUNG-CHIH YANG ; TUNG-HUNG SU ; Wang C.-C; CHI-LING CHEN ; Hsu C.-A; Fang-Tzu Kuo S; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Hepatology | 218 | 195 | |
120 | 2012 | Determinants of spontaneous surface antigen loss in hepatitis B e antigen-negative patients with a low viral load | TAI-CHUNG TSENG ; CHUN-JEN LIU ; HUNG-CHIH YANG ; TUNG-HUNG SU ; Wang C.-C; CHI-LING CHEN ; Fang-Tzu Kuo S; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Hepatology | 129 | 115 | |
121 | 2012 | High levels of hepatitis B surface antigen increase risk of hepatocellular carcinoma in patients with low HBV load | TAI-CHUNG TSENG ; CHUN-JEN LIU ; HUNG-CHIH YANG ; TUNG-HUNG SU ; Wang C.-C; CHI-LING CHEN ; Kuo S.F.-T; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Gastroenterology | 430 | 381 | |
122 | 2012 | Young chronic hepatitis b patients with nucleos(t)ide analogue-induced hepatitis b e antigen seroconversion have a higher risk of HBV reactivation | TAI-CHUNG TSENG ; CHUN-JEN LIU ; TUNG-HUNG SU ; HUNG-CHIH YANG ; Wang C.-C; CHI-LING CHEN ; Kuo S.F.-T; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of Infectious Diseases | 44 | 43 | |
123 | 2012 | Stimulation of HIV-1-Specific Cytolytic T Lymphocytes Facilitates Elimination of Latent Viral Reservoir after Virus Reactivation | Shan L; Deng K; Shroff N.S; Durand C.M; Rabi S.A; HUNG-CHIH YANG ; Zhang H; Margolick J.B; Blankson J.N; Siliciano R.F. | Immunity | 607 | 589 | |
124 | 2012 | Ribavirin Enhances the Action of Interferon-α against Hepatitis C Virus by Promoting the p53 Activity through the ERK1/2 Pathway | Liu W.-L.; HUNG-CHIH YANG ; Su W.-C; Wang C.-C; Chen H.-L; HURNG-YI WANG ; Huang W.-H; DING-SHINN CHEN ; Lai M.-Y. | PLoS ONE | 14 | 14 | |
125 | 2011 | Disulfiram reactivates latent HIV-1 in a Bcl-2-transduced primary CD4+ T cell model without inducing global T cell activation | Xing S; Bullen C.K; Shroff N.S; Shan L; HUNG-CHIH YANG ; Manucci J.L; Bhat S; Zhang H; Margolick J.B; Quinn T.C; Margolis D.M; Siliciano J.D; Siliciano R.F. | Journal of Virology | 163 | 155 | |
126 | 2011 | Influence of host gene transcription level and orientation on HIV-1 latency in a primary-cell model | Shan L; HUNG-CHIH YANG ; Rabi S.A; Bravo H.C; Shroff N.S; Irizarry R.A; Zhang H; Margolick J.B; Siliciano J.D; Siliciano R.F. | Journal of Virology | 95 | 90 | |
127 | 2011 | Primary cell models of HIV latency | HUNG-CHIH YANG | Current Opinion in HIV and AIDS | 17 | 18 | |
128 | 2010 | Minocycline attenuates HIV infection and reactivation by suppressing cellular activation in human CD4+ T cells | Szeto G.L; Brice A; HUNG-CHIH YANG ; Barber S.A; Siliciano R.F; Clements J.E. | Journal of Infectious Diseases | 55 | 49 | |
129 | 2010 | Hepatitis B virus core antigen determines viral persistence in a C57BL/6 mouse model | Lin Y.-J.; Huang L.-R; HUNG-CHIH YANG ; Tzeng H.-T; PING-NING HSU ; Wu H.-L; PEI-JER CHEN ; DING-SHINN CHEN | Proceedings of the National Academy of Sciences of the United States of America | 61 | 59 | |
130 | 2009 | Isolation of a cellular factor that can reactivate latent HIV-1 without T cell activation | HUNG-CHIH YANG ; Shen L; Siliciano R.F; Pomerantz J.L. | Proceedings of the National Academy of Sciences of the United States of America | 36 | 33 | |
131 | 2009 | Small-molecule screening using a human primary cell model of HIV latency identifies compounds that reverse latency without cellular activation | HUNG-CHIH YANG ; Xing S; Shan L; O'Connell K; Dinoso J; Shen A; Zhou Y; Shrum C.K; Han Y; Liu J.O; Zhang H; Margolick J.B; Siliciano R.F. | Journal of Clinical Investigation | 227 | 209 | |
132 | 2008 | Preferential cytolysis of peripheral memory CD4+ T cells by in vitro X4-tropic human immunodeficiency virus type 1 infection before the completion of reverse transcription | Zhou Y; Shen L; HUNG-CHIH YANG ; Siliciano R.F. | Journal of Virology | 16 | 18 | |
133 | 2008 | Preservation of FoxP3+ regulatory T cells in the peripheral blood of human immunodeficiency virus type 1-infected elite suppressors correlates with low CD4+ T-cell activation | Chase A.J; HUNG-CHIH YANG ; Zhang H; Blankson J.N; Siliciano R.F. | Journal of Virology | 108 | 105 | |
134 | 2008 | Orientation-Dependent Regulation of Integrated HIV-1 Expression by Host Gene Transcriptional Readthrough | Han Y; Lin Y.B; An W; Xu J; HUNG-CHIH YANG ; O'Connell K; Dordai D; Boeke J.D; Siliciano J.D; Siliciano R.F. | Cell Host and Microbe | 172 | 163 | |
135 | 2008 | Transmission of human immunodeficiency virus type 1 from a patient who developed AIDS to an elite suppressor | Bailey J.R; O'Connell K; HUNG-CHIH YANG ; Han Y; Xu J; Jilek B; Williams T.M; Ray S.C; Siliciano R.F; Blankson J.N. | Journal of Virology | 89 | 86 | |
136 | 2007 | Novel pathway for induction of latent virus from resting CD4+ T cells in the simian immunodeficiency virus/macaque model of human immunodeficiency virus type 1 latency | Shen A; HUNG-CHIH YANG ; Zhou Y; Chase A.J; Boyer J.D; Zhang H; Margolick J.B; Zink M.C; Clements J.E; Siliciano R.F. | Journal of Virology | 35 | 33 | |
137 | 2007 | Evolution of HIV-1 in an HLA-B*57-positive patient during virologic escape | Bailey J.R; Zhang H; Wegweiser B.W; HUNG-CHIH YANG ; Herrera L; Ahonkhai A; Williams T.M; Siliciano R.F; Blankson J.N. | Journal of Infectious Diseases | 48 | 51 | |
138 | 2007 | Experimental approaches to the study of HIV-1 latency | Han Y; Wind-Rotolo M; HUNG-CHIH YANG ; Siliciano J.D; Siliciano R.F. | Nature Reviews Microbiology | 174 | 156 | |
139 | 2007 | Isolation and characterization of replication-competent human immunodeficiency virus type 1 from a subset of elite suppressors | Blankson J.N; Bailey J.R; Thayil S; HUNG-CHIH YANG ; Lassen K; Lai J; Gandhi S.K; Siliciano J.D; Williams T.M; Siliciano R.F. | Journal of Virology | 239 | 238 | |
140 | 2006 | Neutralizing antibodies do not mediate suppression of human immunodeficiency virus type 1 in elite suppressors or selection of plasma virus variants in patients on highly active antiretroviral therapy | Bailey J.R; Lassen K.G; HUNG-CHIH YANG ; Quinn T.C; Ray S.C; Blankson J.N; Siliciano R.F. | Journal of Virology | 144 | 143 | |
141 | 2005 | Influence of metabolic syndrome, viral genotype and antiviral therapy on superimposed fatty liver disease in chronic hepatitis C | CHUN-JEN LIU ; YUNG-MING JENG ; PEI-JER CHEN ; Lai M.-Y; HUNG-CHIH YANG ; Huang W.-L; JIA-HORNG KAO ; DING-SHINN CHEN | Antiviral Therapy | 34 | 32 | |
142 | 2005 | Cellular immune selection with hepatitis C virus persistence in humans | Cox A.L; Mosbruger T; Mao Q; Liu Z; Wang X.-H; HUNG-CHIH YANG ; Sidney J; Sette A; Pardoll D; Thomas D.L; Ray S.C. | Journal of Experimental Medicine | 260 | 241 |